Feng, Xiu E. published the artcileProcess development and synthesis of process-related impurities of an efficient scale-up preparation of 5,2′-dibromo-2,4′,5′-trihydroxy diphenylmethanone as a new acute pyelonephritis candidate drug, Product Details of C9H10O3, the main research area is acute pyelonephritis drug synthesis LM49API; 5,2′-dibromo-2,4′,5′-trihydroxydiphenylmethanone; acute pyelonephritis; polymorph; process development; process-related impurity.
Based on a foregoing gram-scale laboratory process, an efficient scale-up preparation process of 5,2′-dibromo-2,4′,5′-trihydroxydiphenylmethanone (LM49-API), a new acute pyelonephritis candidate drug, was developed and validated aiming to reduce byproducts and achieve better impurity profiles. Meanwhile, the polymorph of LM49-API and process-related impurities were also investigated. Ultimately, the optimal reaction conditions were verified by evaluating the impurity profiles and their formation during the synthesis. Six process-related impurities were synthesized and identified, being useful for the quality control of LM49-API. Its finalized preparation process was further validated at 329-410 g scale-up production in 53.4-57.1% overall yield with 99.95-99.98% high-performance liquid chromatog. (HPLC) purity, and it is currently viable for com. production LM49-API-imC and LM49-API-imX were identified as the main single impurities in LM49-API, with the content controlled to be less than 0.03%.
Molecules published new progress about Temperature effects, biological. 86-51-1 belongs to class isoquinoline, name is 2,3-Dimethoxybenzaldehyde, and the molecular formula is C9H10O3, Product Details of C9H10O3.
Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem